Page Amy Theresa, Potter Kathleen, Naganathan Vasi, Hilmer Sarah, McLachlan Andrew J, Lindley Richard I, Coman Tracy, Mangin D, Etherton-Beer Christopher
Centre for Optimisation of Medicines, School of Allied Health, The University of Western Australia, Crawley, Western Australia, Australia; WA Centre for Health and Ageing, The University of Western Australia, Perth, Western Australia, Australia.
Ryman Healthcare, Christchurch, New Zealand.
Arch Gerontol Geriatr. 2023 Feb;105:104849. doi: 10.1016/j.archger.2022.104849. Epub 2022 Nov 4.
To describe medicines regimens used by older people living in residential aged care facilities (RACFs).
This cross-sectional study presents baseline data from a randomised controlled trial in seventeen Australian RACFs that recruited residents aged 65 years and older at the participating facilities. The main outcome measures were to evaluation of medicines utilisation, including the number of medicines, medicine regimen complexity, potential under-prescribing and high-risk prescribing (prescribing cascades, anticholinergic or sedative medicines or other potentially inappropriate medicines) with data analysed descriptively.
Medicines regimens were analysed for 303 residents (76% female) with a mean age of 85.0 ± 7.5 years, of whom the majority were living with dementia (72%). Residents were prescribed an average of 10.3 ± 4.5 regular medicines daily. Most participants (85%) had highly complex regimens. Most residents (92%) were exposed to polypharmacy (five or more medicines). Nearly all, 302 (98%) residents had at least one marker of potentially suboptimal prescribing. At least one instance of potential under-prescribing was identified in 86% of residents. At least one instance of high-risk prescribing was identified in 81% of residents including 16% of participants with at least one potential prescribing cascade.
CONCLUSION(S): Potentially suboptimal prescribing affected almost all residents in this study, and most had highly complex medicines regimens. If generalisable, these findings indicate most older people in RACFs may be at risk of medicines-related harm from suboptimal prescribing, in addition to the burden of administration of complex medicines regimens for facility staff and residents.
描述居住在老年护理机构(RACFs)中的老年人所使用的药物治疗方案。
这项横断面研究呈现了一项随机对照试验的基线数据,该试验在澳大利亚17家RACFs中开展,招募了参与机构中65岁及以上的居民。主要结局指标是评估药物使用情况,包括药物数量、药物治疗方案的复杂性、潜在的处方不足和高风险处方(处方级联、抗胆碱能或镇静药物或其他潜在不适当药物),并对数据进行描述性分析。
对303名居民(76%为女性)的药物治疗方案进行了分析,平均年龄为85.0±7.5岁,其中大多数患有痴呆症(72%)。居民每天平均服用10.3±4.5种常规药物。大多数参与者(85%)的治疗方案高度复杂。大多数居民(92%)使用多种药物(五种或更多药物)。几乎所有302名(98%)居民都有至少一项潜在不适当处方的指标。86%的居民被确定至少有一例潜在处方不足。81%的居民被确定至少有一例高风险处方,包括16%的参与者至少有一次潜在的处方级联。
潜在的不适当处方影响了本研究中几乎所有居民,且大多数人的药物治疗方案高度复杂。如果这些结果具有普遍性,那么表明除了复杂药物治疗方案给机构工作人员和居民带来的管理负担外,大多数RACFs中的老年人可能因处方不当而面临药物相关伤害的风险。